T1	Concept 4 12	CoViD-19
T2	Concept 46 52	severe
T3	Concept 61 66	drugs
T4	Concept 67 73	so far
T5	Action 86 93	capable
T6	Concept 110 115	viral
T7	Concept 116 122	growth
R1	has-property Arg1:T7 Arg2:T6	
T8	Action 97 105	stemming
R2	target Arg1:T8 Arg2:T7	
R3	target Arg1:T5 Arg2:T8	
R4	subject Arg1:T5 Arg2:T3	
A1	Negated T5
R5	in-time Arg1:T5 Arg2:T4	
R6	has-property Arg1:T1 Arg2:T2	
A2	Emphasized T2
R7	in-context Arg1:T6 Arg2:T1	
T9	Action 138 146	increase
T10	Concept 150 158	COVID-19
T11	Concept 159 168	mortality
R8	target Arg1:T9 Arg2:T11	
T12	Action 196 201	lower
T13	Concept 202 210	humidity
T14	Concept 214 220	winter
R9	target Arg1:T12 Arg2:T13	
R10	in-time Arg1:T12 Arg2:T14	
R11	in-context Arg1:T9 Arg2:T10	
T15	Action 181 188	related
A3	Uncertain T15
R12	subject Arg1:T15 Arg2:T9	
R13	target Arg1:T15 Arg2:T12	
T16	Action 257 267	persistent
T17	Concept 252 256	more
T18	Concept 237 247	infections
T19	Concept 224 236	asymptomatic
R14	is-a Arg1:T19 Arg2:T18	
T20	Concept 273 284	symptomatic
R15	is-a Arg1:T20 Arg2:T18	
R16	has-property Arg1:T16 Arg2:T17	
R17	subject Arg1:T16 Arg2:T19	
R18	in-context Arg1:T17 Arg2:T20	
A4	Uncertain T17
T21	Concept 311 319	interval
T22	Concept 295 299	mean
R19	has-property Arg1:T21 Arg2:T22	
T23	Concept 324 332	COVID-19
T24	Action 300 310	generation
R20	in-context Arg1:T21 Arg2:T24	
R21	target Arg1:T24 Arg2:T23	
T25	Action 342 348	longer
A5	Uncertain T25
T26	Concept 369 380	symptomatic
T27	Concept 354 363	estimated
T28	Concept 381 386	cases
R22	has-property Arg1:T28 Arg2:T26	
R23	subject Arg1:T25 Arg2:T21	
R24	in-context Arg1:T27 Arg2:T28	
T29	Concept 387 392	alone
R25	has-property Arg1:T27 Arg2:T29	
R26	target Arg1:T25 Arg2:T28	
R27	entails Arg1:T16 Arg2:T25	
T30	Action 397 407	protection
T31	Action 409 420	maintenance
T32	Action 424 433	promotion
T33	Concept 448 454	levels
T34	Action 502 511	treatment
T35	Action 487 497	prevention
T36	Action 473 479	effect
T37	Concept 515 523	COVID-19
T38	Concept 468 472	good
R28	has-property Arg1:T36 Arg2:T38	
A6	Uncertain T36
T39	Concept 437 447	lymphocyte
R29	in-context Arg1:T33 Arg2:T39	
R30	target Arg1:T30 Arg2:T33	
R31	target Arg1:T31 Arg2:T33	
R32	target Arg1:T32 Arg2:T33	
R33	target Arg1:T36 Arg2:T35	
R34	target Arg1:T36 Arg2:T34	
R35	target Arg1:T35 Arg2:T37	
R36	target Arg1:T34 Arg2:T37	
R37	subject Arg1:T36 Arg2:T32	
R38	subject Arg1:T36 Arg2:T31	
R39	subject Arg1:T36 Arg2:T30	
T40	Concept 535 546	temperature
T41	Action 547 556	screening
T42	Concept 564 573	high-risk
T43	Concept 577 587	population
R40	has-property Arg1:T43 Arg2:T42	
T44	Action 611 625	identification
T45	Concept 605 610	early
R41	has-property Arg1:T44 Arg2:T45	
T46	Concept 629 637	COVID-19
T47	Concept 638 647	infection
R42	in-context Arg1:T47 Arg2:T46	
T48	Action 660 668	reducing
T49	Concept 673 677	risk
T50	Concept 681 686	cross
T51	Concept 687 696	infection
R43	has-property Arg1:T51 Arg2:T50	
R44	target Arg1:T48 Arg2:T49	
R45	in-context Arg1:T49 Arg2:T51	
R46	target Arg1:T44 Arg2:T47	
R47	target Arg1:T41 Arg2:T40	
R48	in-place Arg1:T41 Arg2:T43	
T52	Concept 591 600	important
R49	has-property Arg1:T41 Arg2:T52	
R50	in-context Arg1:T52 Arg2:T44	
R51	in-context Arg1:T52 Arg2:T48	
